‘Main Issue’ Facing Generics Security Of Supply Is Price, Politico Panel Hears
European Industry Calls For Fast Implementation Of Transparent Pricing Models
Panelists discussed the issues jeopardizing generics security of supply, the potential impact of pricing changes and international best practice at a recent Politico event.
You may also be interested in...
Medicines for Europe has expressed its support for a non-paper already adhered to by 21 EU member states, which proposes a number of solutions which could improve security of supply for medicines in the region.
European healthcare leaders debated the usefulness of joint procurement and state aid for the generics and biosimilars companies at a recent Politico panel, in light of rising inflation across the continent.
Australia’s branded and generic drug industry associations have jointly raised concerns about the impact ongoing shortages could have on the country’s supply of medicines.